NIH Seeks Two Human Research Protection Officers
NIH seeks scientists to provide expert advice on human subjects protection issues related to NIH extramural programs.
NIH seeks scientists to provide expert advice on human subjects protection issues related to NIH extramural programs.
A new report explores the potential for pharmacogenomics (PGx) to advance the development of strategies to improve the safety and quality of health care; identify opportunities and barriers in need of the Federal Government’s attention; and make policy recommendations to enhance the development and integration of PGx applications.
0 Comments
The NIH Program on Clinical Research Policy Analysis and Coordination recently augmented their bioethics resources on the web with the addition of a compilation of international guidelines, codes, regulations, policies, and declarations.
0 Comments
Data on compact disks sent to peer reviewers prior to study section meetings are being password protected as of May 15, 2008 to enhance the confidentiality of the peer review process.
0 Comments
NIH plans to transition from PureEdge to Adobe version of the SF424 (R&R) in December 2008 and schedules transition of many remaining mechanisms.
0 Comments
NIH updated the Public Access FAQ this month to provide procedural changes and clarifications. Also, the NIH Public Access Request for Information ends May 31.
0 Comments
Despite recent efforts, compliance issues with financial conflict of interest policies continue. The three major concerns are: too narrow a definition of investigator, the timing of reporting and ensuring subrecipients comply with the regulation.
0 Comments
These seminars will deliver information in a streamlined format, directly to your office without the expense, inconvenience, and time commitment of travel.
0 Comments
Challenges and Promise of Cell-Based Therapies is a one-day symposium to explore promising research in regenerative medicine using stem cells.
0 Comments
A recent OMB decision allows NIH to continue using eRA systems and servicing our partner agencies.
0 Comments
0 Comments